BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 11042531)

  • 1. Effect of ubenimex (Bestatin) on the cell growth and phenotype of HL-60 and HL-60R cell lines: up-and down-regulation of CD13/aminopeptidase N.
    Imamura N; Kimura A
    Leuk Lymphoma; 2000 May; 37(5-6):663-7. PubMed ID: 11042531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukemic cell-surface CD13/aminopeptidase N and resistance to apoptosis mediated by endothelial cells.
    Mishima Y; Matsumoto-Mishima Y; Terui Y; Katsuyama M; Yamada M; Mori M; Ishizaka Y; Ikeda K; Watanabe J; Mizunuma N; Hayasawa H; Hatake K
    J Natl Cancer Inst; 2002 Jul; 94(13):1020-8. PubMed ID: 12096087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rotenone, a mitochondrial NADH dehydrogenase inhibitor, induces cell surface expression of CD13 and CD38 and apoptosis in HL-60 cells.
    Matsunaga T; Kudo J; Takahashi K; Dohmen K; Hayashida K; Okamura S; Ishibashi H; Niho Y
    Leuk Lymphoma; 1996 Feb; 20(5-6):487-94. PubMed ID: 8833408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of apoptosis by bestatin (ubenimex) in human leukemic cell lines.
    Sekine K; Fujii H; Abe F
    Leukemia; 1999 May; 13(5):729-34. PubMed ID: 10374877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of sensitivity by bestatin of acute promyelocytic leukemia NB4 cells to all-trans retinoic acid.
    Hirano T; Kizaki M; Kato K; Abe F; Masuda N; Umezawa K
    Leuk Res; 2002 Dec; 26(12):1097-103. PubMed ID: 12443882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of APN/CD13 on bestatin enhancing all-trans-retinoic acid-inducing differentiation in NB4 cells].
    Qian XJ; Lin MF
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Oct; 19(5):1125-8. PubMed ID: 22040956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of p38 MAPK Phosphorylation Is Critical for Bestatin to Enhance ATRA-Induced Cell Differentiation in Acute Promyelocytic Leukemia NB4 Cells.
    Qian X; He J; Zhao Y; Lin M
    Am J Ther; 2016; 23(3):e680-9. PubMed ID: 24141198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of aminopeptidase N (EC 3.4.11.2; APN; CD13) by interferon-gamma on the HL-60 cell line.
    Gabrilovac J; Breljak D; Cupić B; Ambriović-Ristov A
    Life Sci; 2005 Apr; 76(23):2681-97. PubMed ID: 15792835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aminopeptidase N (APN)/CD13 inhibitor, Ubenimex, enhances radiation sensitivity in human cervical cancer.
    Tsukamoto H; Shibata K; Kajiyama H; Terauchi M; Nawa A; Kikkawa F
    BMC Cancer; 2008 Mar; 8():74. PubMed ID: 18366676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of aminopeptidase N on human choriocarcinoma cells and cell growth suppression by the inhibition of aminopeptidase N activity.
    Ino K; Goto S; Okamoto T; Nomura S; Nawa A; Isobe K; Mizutani S; Tomoda Y
    Jpn J Cancer Res; 1994 Sep; 85(9):927-33. PubMed ID: 7961121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancing effect of ubenimex (bestatin) on proliferation and differentiation of hematopoietic progenitor cells, and the suppressive effect on proliferation of leukemic cell lines via peptidase regulation.
    Shibuya K; Chiba S; Hino M; Kitamura T; Miyagawa K; Takaku F; Miyazano K
    Biomed Pharmacother; 1991; 45(2-3):71-80. PubMed ID: 1912372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of the expression of aminopeptidase A, aminopeptidase N/CD13 and dipeptidylpeptidase IV/CD26 in renal carcinoma cells and renal tubular epithelial cells by cytokines and cAMP-increasing mediators.
    Kehlen A; Göhring B; Langner J; Riemann D
    Clin Exp Immunol; 1998 Feb; 111(2):435-41. PubMed ID: 9486416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and synthesis of novel chloramphenicol amine derivatives as potent aminopeptidase N (APN/CD13) inhibitors.
    Yang K; Wang Q; Su L; Fang H; Wang X; Gong J; Wang B; Xu W
    Bioorg Med Chem; 2009 Jun; 17(11):3810-7. PubMed ID: 19423354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LYP, a novel bestatin derivative, inhibits cell growth and suppresses APN/CD13 activity in human ovarian carcinoma cells more potently than bestatin.
    Gao JJ; Gao ZH; Zhao CR; Yuan Y; Cui SX; Zhang XF; Cheng YN; Xu WF; Tang W; Qu XJ
    Invest New Drugs; 2011 Aug; 29(4):574-82. PubMed ID: 20111888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel vitamin D(3) analog, 21-(3-methyl-3-hydroxy-butyl)-19-nor D(3), that modulates cell growth, differentiation, apoptosis, cell cycle, and induction of PTEN in leukemic cells.
    Hisatake J; O'Kelly J; Uskokovic MR; Tomoyasu S; Koeffler HP
    Blood; 2001 Apr; 97(8):2427-33. PubMed ID: 11290607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effects of bestatin in the retina of streptozotocin-induced diabetic mice.
    Hossain A; Heron D; Davenport I; Huckaba T; Graves R; Mandal T; Muniruzzaman S; Wang S; Bhattacharjee PS
    Exp Eye Res; 2016 Aug; 149():100-106. PubMed ID: 27344955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leucine ureido derivatives as aminopeptidase N inhibitors using click chemistry. Part II.
    Cao J; Zang J; Kong X; Zhao C; Chen T; Ran Y; Dong H; Xu W; Zhang Y
    Bioorg Med Chem; 2019 Mar; 27(6):978-990. PubMed ID: 30737134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel leucine ureido derivatives as aminopeptidase N inhibitors using click chemistry.
    Cao J; Ma C; Zang J; Gao S; Gao Q; Kong X; Yan Y; Liang X; Ding Q; Zhao C; Wang B; Xu W; Zhang Y
    Bioorg Med Chem; 2018 Jul; 26(12):3145-3157. PubMed ID: 29859750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and activity evaluation of a new bestatin derivative LYP2 as an aminopeptidase N inhibitor.
    Luan Y; Wang Q; Liu N; Mou J; Jiao X; Fang H; Li M; Xu W
    Anticancer Drugs; 2011 Jan; 22(1):99-103. PubMed ID: 21048494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New Method for Detecting the Suppressing Effect of Enzyme Activity by Aminopeptidase N Inhibitor.
    Liu H; Wang X; Yang H; Zhao Y; Ji S; Ma H; Zhou Y; Wang Y; Zhang H; Jiang W; Fang C; Feng L; Wang X
    Chem Pharm Bull (Tokyo); 2019; 67(2):155-158. PubMed ID: 30713276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.